| |
Pediatric
Academic Societies'
Annual Meeting
|

|
|
|
Contact
Information |
|
Mail
Address:
3400
Research Forest Dr., Ste B-7
The Woodlands, TX 77381 USA
Email:
info@pas-meeting.org
Telephone:
281-419-0052
Facsimile:
281-419-0082
|
|
 |
2005
PAS Annual Meeting
May
14 –17
Washington, DC
Washington
Convention Center
Renaissance Washington Hotel
|
|
|
2005
Late-Breaker Abstract Sessions |
|
Saturday,
May 14
3:15pm–5:15pm
4855
Late Breakers I:
Late Breaking Research in Pediatrics
PAS
Platform Session ~ WCC, Room 204 AB
Moderator: Paul Young
|
Monday,
May 16
3:00pm–5:00pm
6750
Late Breakers II:
Clinical Research in Neonatology
PAS
Platform Session ~ WCC, Room 147
Moderators:
Neil Finer and Richard Martin
|
|
3:15* |
A Simple Method To Identify GNAS1 Gene
Mutation from Peripheral Lymphocytes. A Tip for Genetic Diagnosis of
GNAS1 Related Multiple Endocrinopathies Among Masked
Somatic Mosaicism. Katsuaki Motomura.
(Late-Breaker
Abstract 1)
|
3:00 |
Efficacy
and Safety of Methylxanthines in Very-Low-Birth
Weight (VLBW) Infants: Preliminary Results from
the International Caffeine for Apnea of
Prematurity (CAP) Trial. Barbara
Schmidt, Robin Roberts, Peter Davis, Lex Doyle,
Keith Barrington, Arne Ohlsson, Alfonso Solimano,
Win Tin, The CAP Investigators.
(Late-Breaker Abstract 9)
|
|
3:30* |
Procalcitonin as a Predictor of
Vesicoureteral Reflux After a 1st Urinary Tract
Infection in Children: European Validation Study.
S.
Leroy, C. Romanello, A. Galetto-Lacour, V. Smolkin,
B. Korczowski, C. Rodrigo, D. Tuerlinckx, V. Gajdos,
M. Contardo, A. Gervaix, R. Halevy, B. Duhl, C. Prat,
T. Vander Borght, L. Foix L’Hélias, D. Gendrel,
G. Bréart, M. Chalumeau. (Late-Breaker
Abstract 2) |
3:15 |
Population-Based
Study of Neonatal Outcomes Following Prenatal SSRI
Exposure Using the BC Health Linked Data. Tim
F. Oberlander, William Warburton, Jaafar
Aghajanian, Clyde Hertzman. (Late-Breaker Abstract 10) |
|
3:45 |
Live Attenuated Influenza Vaccine
(LAIV)
Administration in Schoolchildren Coincident with the
2003–2004 Outbreak Provided Herd Immunity Against
a Drifted Influenza Variant A/Fujian/411/2002
(H3N2).
Manjusha J. Gaglani, Pedro A. Piedra, Gayla
Herschler, Charles Fewlass, W.P. Glezen.
(Late-Breaker
Abstract 3)
|
3:30 |
Multicenter
Randomized Double-Blind Placebo Controlled Trial
of Ibuprofen L-Lysine Intravenous Solution (IV
Ibuprofen) in Premature Infants for the Early
Treatment of Patent Ductus Arteriosus (PDA).
J.V.
Aranda for the I.V. Ibuprofen–PDA Study Team and
for the Pediatric Pharmacology Research Unit
Network (NICHD-PPRU). (Late-Breaker Abstract 11) |
|
4:00 |
Reducing Early Childhood Overweight:
Pediatric Practice Results from a Rural Community
Intervention.
Barbara A. Dennison, Kathleen F. Sellers, Claire T.
Sellers, Ida R. Baker, Patrick A. Burdick.
(Late-Breaker
Abstract 4) |
3:45 |
Cluster
Randomized Trial of Benchmarking To Improve
Survival Free of Bronchopulmonary Dysplasia (BPD).
M. Walsh, A. Laptook, S. Buchter, W.A. Engle, M.
Rasmussen, S.N. Kazzi, Q. Yao, G. Heldt, W. Rhine,
R. Higgins for the NICHD Neonatal Research
Network. (Late-Breaker Abstract 12) |
|
4:15 |
Novel Strategy for Delivering Influenza
Vaccine to Household Contacts of Infants Less Than 6
Months Old.
Donna H. Jordan, Ruth A. Merryman, Jane D. Siegel.
(Late-Breaker
Abstract 5)
|
4:00 |
A
Community-Based, Randomized Trial of Newborn Skin
Cleansing with Chlorhexidine on Neonatal Mortality
in Southern Nepal. James
M. Tielsch, Gary Darmstadt, Luke C. Mullany,
Subarna K. Khatry, Joanne Katz, Steven C. LeClerq,
Shardaram Shrestha, Ramesh Adhikari.
(Late-Breaker Abstract 13) |
|
4:30 |
Medication Errors in Ambulatory Pediatric
Patients. Rainu Kaushal, Donald A. Goldmann, Carol A.
Keohane,
Melissa Honour, David W. Bates.
(Late-Breaker
Abstract 6) |
4:15 |
Does
the Introduction of Nasal CPAP Improve Respiratory
Outcomes in Premature Infants?
Gustavo Pelligra, Mohamed A Abdellatif,
Shoo K. Lee. (Late-Breaker
Abstract 14) |
|
4:45 |
The Effectiveness of a Pentavalent
(Human-Bovine) Reassortant Rotavirus Vaccine (PRV)
To Reduce Hospitalizations and Emergency Department
(ED) Visits for Rotavirus Gastroenteritis. R.
Itzler, D. Matson, T.
Vesikari, M. Coia, J. Cook, G. Davies, P.
Heaton, J. Heyse, G. Koch for REST Study Team.
(Late-Breaker
Abstract 7) |
4:30 |
Randomized
Controlled Trial for the Prevention of
Intraventricular Hemorrhage by Indomethacin in
Japanese Extremely Low Birthweight Infants.
Masanori Fujimura, Shinya Hirano, Satoshi Kusuda,
Hirofumi Aotani, Noriyuki Nakanishi.
(Late-Breaker Abstract 15) |
|
5:00 |
Human Coronavirus
(HCoV) NL-63 in the
Respiratory Tract Is Not Associated with Acute
Kawasaki Syndrome (KS). Jane
C. Burns, Hiroko Shike, Chisato Shimizu, Sharon L.
Reed, John V. Williams, Susan C. Baker, Vivek R.
Nerurkar, Saguna Verma, Richard Yanagihara, Marian E
Melish, Stanford T. Shulman, Anne H. Rowley.
(Late-Breaker
Abstract 8) |
4:45 |
Long-Term
Outcomes of the Novel Peptide-Containing Synthetic
Surfactant, Lucinactant (Surfaxin[reg]) vs.
Animal-Derived and Synthetic, Non–Protein-Containing
Synthetic Surfactants in Very Preterm Infants.
Fernando Moya, Sunil Sinha, Janusz Gadzinowski,
Robert Segal, Jan Mazela, Carlos Guardia, Genzhou
Liu. (Late-Breaker
Abstract 16) |
|
|
|
|
|
|
|
|
|
|
|
|
PDF files require the use of
the free Adobe Acrobat Reader. Click here if you need to
download this file to your computer.
|
|
Copyright:
All information contained in this Website is the property
of the Pediatric Academic Societies unless otherwise noted.
Duplication of any information contained herein for
reasons other than personal use requires the expressed
written permission of PAS. For comments or concerns
about the website, please contact webmaster@pas-meeting.org.
Last Updated: September 26, 2006
|